JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIGGER, J. T.
Right arrow Articles by MANDEL, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIGGER, J. T., JR.
Right arrow Articles by MANDEL, W. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 172, Issue 2, 239-254, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF LIDOCAINE ON CONDUCTION IN CANINE PURKINJE FIBERS AND AT THE VENTRICULAR MUSCLE-PURKINJE FIBER JUNCTION

J. THOMAS BIGGER JR. 1 and WILLIAM J. MANDEL 1

1 Departments of Pharmacology and Medicine, College of Physicians and Surgeons, Columbia University, New York, New York

The purpose of this study was to determine in Purkinje fibers (PF) the effects of lidocaine on conduction and its determinants and to measure its effects on conduction and refractoriness at the ventricular muscle-Purkinje fiber junction (VM-PFJ). Preparations of papillary muscle and false tendon (Purkinje fibers) were obtained from dog hearts, placed in a bath perfused with Tyrode's solution, stimulated electrically and studied under control conditions and during perfusion with lidocaine. Transmembrane voltage (TMV) of ventricular muscle and of PF was recorded with microelectrodes. The effects of lidocaine on the characteristics of PF phase O depolarization, membrane responsiveness, conduction velocity and on conduction and refractoriness at the VM-PFJ were studied. A 1 x 10-5 M lidocaine concentration produced effects thought to be equivalent to those seen after therapeutic doses in vivo. In PF, this concentration reduced automaticity and produced a maximal decrease in the duration of the action potential and effective refractory period without showing significant effects on maximal diastolic TMV or action potential amplitude and overshoot. This concentration of lidocaine had three effects on membrane responsiveness: 1) it shifted Vi (the least negative TMV at which the PF can be activated) to more negative values; 2) it steepened the slope of the relationship between phase 0 Vmax and membrane activation voltage (MAV); and 3) it increased peak Vmax. Conduction velocity in PF either increased or did not change after application of 1 x 10-5 M lidocaine and conduction was markedly enhanced and refractoriness abbreviated at the VM-PFJ. High concentrations (ge1 x 10-4 M) produced decreases in maximal diastolic TMV and in the amplitude, overshoot and Vmax of phase 0 depolarization. These concentrations: 1) caused shifts in Vi to even more negative values of TMV; 2) shifted Vh (the TMV at which Vmax is half the peak value) to more negative TMV; and 3) decreased peak Vmax. At these concentrations, PF conduction velocity was significantly reduced and conduction and refractoriness at the VM-PFJ were prolonged over the values found at lower lidocaine concentrations.

Submitted on October 3, 1969
Accepted on December 12, 1969




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
P. A. Chiale, D. A. Franco, H. O. Selva, C. A. Militello, and M. V. Elizari
Lidocaine-sensitive atrial tachycardia: Lidocaine-sensitive, rate-related, repetitive atrial tachycardia: a new arrhythmogenic syndrome
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1637 - 1645.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.